浅述严重感染和感染性休克的药物治疗法

禹烜 苗(新乡医学院第一附属医院，中国)

摘要

严重感染和感染性休克是各种严重创伤、烧伤、缺氧、再灌注损伤及外科大手术常见的并发症，目前感染性休克的病死率仍高达50%以±0根据循证医学规范医疗措施，有助于改善其临床防治。

关键词

严重感染；感染性休克；治疗；循证医学

参考

Phillip DR, Jean MC,Henry M,et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med, 2004, 32(3):858-873.

Rivers E, Nguyen B, Havstad S,et al. Earlygoal-directed therapy in the treat¬ment of severe sepsis and septic shock. N Engl J Med, 2001, 345(19):1368-1377.

Hollenberg SM, Ahrens TS, Astiz ME, et al. Practice parameters for hemody¬namic support of sepsis in adult patients.Crit Care Med, 1999, 27(3):639-660.

Sharshar T, Blanchard A, Paillard M, et al. Circulating vasopressin levels in septic shock. Crit Care Med, 2003,31(6):1752—1758.

Annane D, Sebille V, Charpentier C, et al. Effect of treatment with low doses of hydrocortisoneand fludrocortisone on mortality in patients with septic shock. JAMA, 2002, 288(7):862-871.

Briegel J, Forst H, Haller M, et al. Stress doses of hydrocortisone reverse hyper-dynamic septic shock A prospective, ran¬domized, double-blind, single-center study. Crit Care Med, 1999, 27(4): 723-732.

Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med, 2001, 344(10):699-709.

Van den Berghe G, Wouters P, Wee- kers E et al. Intensive insulin therapy in the critically ill patients. N Engl J Med, 2001,345(19):1359-1367.

Finney SJ, Zekveld C, Elia A, et al. Glucose control and mortality in critically ill patients. JAMA, 2003, 290(15):2041-2047.

Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefit of inten¬sive insulin therapy in the critically ill: Insu¬lin dose versus glycolic control. Crit Care Med, 2003, 31(2):359-366.

DOI: http://dx.doi.org/10.26549/nimp.v1i1.5437